Accelerate the transition from molecular design to industrial production

Focusing on customized synthesis, process development, and analytical testing, we provide customers with efficient and accurate chemical research and development solutions.
Chemistry Research Service

Chemical Regulatory Compliance & Registration Services

Our professional team provides global regulatory consulting and registration services to ensure product compliance and quick entry into the market.
Regulatory

Customized molecular building blocks accelerate innovative R&D services

Provide high-quality molecular building blocks to support drug research and chemical synthesis, and assist in the discovery and development of innovative drugs.
Building Block

Chemical safety compliance and quality verification

Provide detailed SDS (Safety Data Sheet) and COA (Certificate of Analysis) to ensure transparency and reliability of product quality and safety information.
SDS/COA Download

Zhaowu Technology

Since its establishment in 2002, the company has researched and developed hundreds of precious metal heterogeneous catalysts and a series of homogeneous catalysts, and successfully realized industrialization. At the same time, it has continuously improved and improved the performance of existing products and the recycling and reprocessing technology of used catalysts, and its market share has continued to increase. improve

Recently, the team of Chen Qingan, a researcher at the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, has made new progress in the reuse of halogenated organic pollutants. They developed a bromide-catalyzed chlorine transfer reaction that can utilize halogenated organic pollutants as halogen sources to achieve the reuse of different
JULY  
07-2024
Recently, Professor Zhang Guoqing's team at the Hefei National Research Center for Microscale Physical Sciences at the University of Science and Technology of China reported the discovery of a new mode of interaction between organic molecules: that is, a stable light-induced charge transfer complex can be formed between aromatic imides and aliphatic amines , and systematically studied the properties and formation process of the complex through steady-state and time-resolved emission spectra, absorption spectra, mass spectrometry, paramagnetic resonance spectroscopy, etc., and proved that the complex can be used for light-induced polymerization and carbon dioxide photoreduction. , UV energy storage and other fields. The result was published in Chem under the title "Trapping Highly Reactive Photo-Induced Charge-Transfer Complex Between Amine and Imide by Light".
JULY  
07-2024
Hair loss is a "top" problem that bothers many people. Previous scientific research has shown that genetics, immunity, excessive mental stress, staying up late, and drugs (such as chemotherapy for hair loss) can cause hair loss. A recent study shows that ubiquitous microplastics can also cause hair loss.
JULY  
07-2024
Professor Chen Yifeng's research group from the School of Chemistry and Molecular Engineering of East China University of Science and Technology and Ferlinga Joint Research Center for Nobel Prize Scientists has made new progress in asymmetric multi-component coupling reactions of alkenes. Relevant research was published online in the Journal of the American Chemical Society.
JULY  
07-2024
As the domestic petrochemical industry pays increasing attention to production safety, enterprises such as Yangzi Petrochemical are also constantly exploring and practicing, striving to adopt more advanced anti-explosion design in building structure design. Roxtec sealing system, with its reliable safety performance, has become the ideal choice for many chemical companies. It can not only withstand the strong impact of the explosion, but also ensure the structural integrity of the building, so that it maintains its original anti-explosion performance.
AUGUST  
08-2024
New data progress: PSMA/CD3 pro-antibody JANX007 is in phase 1 for the treatment of mCRPC and interim clinical data for EGFR/CD3 pro-antibody JANX008 is in phase 1 for the treatment of solid tumors; GLP-1/GIP receptor agonist VK2735 has phase 2 VENTURE trial results in obese patients; ERK/NFκB inhibitor NE3107 has announced phase 2a data for PD (Parkinson's disease) and phase 3 data for AD (Alzheimer's disease); KIT monoclonal antibody Barzolvolimab has phase 2 12-week results for the treatment of CSU; CD45 iodine RDC Iomab-B is in phase 3 for the treatment of AML and announced phase 3 SIERRA trial results
AUGUST  
08-2024
On May 8,20024, Zaiding Pharmaceutical announced the financial performance of 24Q1, and on May 9, it directly closed with a 20 + CM increase. This was the first time since Zaiding Pharmaceutical was listed in Hong Kong in 2020
AUGUST  
08-2024
A single variety, the resignation of the general manager, more than 5% of major shareholders dealing with reducing their holdings for three consecutive years, and construction businessmen as the leaders, all these topics are focused on a young pharmaceutical company - Elise. But even so, it still couldn't stop Ellis from rising from the lowest price of around 15 yuan after its IPO to the latest price of around 60 yuan, and it only took 2 years to achieve a stock price increase of about 3 times from the bottom to now.
AUGUST  
08-2024

Advantages

Comprehensive technical capabilities
Powerful technical team
Compliance and Regulatory Experience
Understand the regulatory requirements of major global drug regulatory agencies
Global layout
Providing services to global pharmaceutical companies
Technical Support
Strictly adhere to GMP